{"id":"HHS-OASH-2026-0397-2898","number":"2898","name":"Blair Dobson","organization":"","posted":"2026-10-14T04:00Z","received":"2026-10-11T04:00Z","body":"I submit these comments as an individual consumer and concerned family member (Q2). People cannot readily opt out of ambient exposure from nearby antennas. I urge federal agencies to reassess whether existing limits adequately address lifelong, real-world exposures, including for children and ecosystems.\n\nQ3–4: Sources of concern include cell towers/small cells, phones, Wi-Fi, Bluetooth, smart meters, and wearables. People report headaches, sleep disruption, fatigue, and other symptoms they associate with RF exposure. Investigate these reports systematically without assuming causation. I report no personal diagnosis or clinical observations. Agencies should collect nonidentifying reports documenting device/source, measured exposure, timing, symptoms, medical evaluation, and changes after exposure reduction, using blinded tests where feasible.\n\nQ5–6: Compare FCC limits with ICNIRP 2020 and IEEE standards, WHO reviews, and IARC assessments. Explain how limits address frequency, SAR, power density, modulation, duty cycle, beamforming, distance, exposure duration, and multiple sources. The U.S. National Toxicology Program reported clear evidence of malignant heart schwannomas in male rats under specific high-level RF exposure conditions; these results do not establish risks from everyday 5G exposure. IARC classified RF fields as “possibly carcinogenic” (Group 2B) in 2011. Recent human reviews, however, found no increased risk for several studied cancers. Assess studies below limits and distinguish cellular changes from proven harm.\n\nQ7–9: Use calibrated broadband and frequency-selective meters, personal dosimeters, SAR testing, and validated modeling. Measure actual exposures across locations and times, including indoors, during peak traffic, and from multiple sources. Publish accessible antenna locations, operating characteristics, compliance methods, measured exposure ranges, uncertainties, and ways to request independent review.\n\nQ10–11: Build privacy-protective surveillance combining cancer registries, occupational and environmental monitoring, longitudinal cohorts, and voluntary adverse-event reports. Investigate clusters with comparison groups; reports are not proof. Biomarkers for individual RF dose are not established. Prioritize children, pregnant people, older adults, workers near transmitters, people with implanted medical devices (including interference risks), and people with preexisting conditions. Evaluate symptoms reported by people identifying as electromagnetically hypersensitive without presuming an RF cause.\n\nQ12–13: Investigate reproducible biological findings reported below some limits, while recognizing that a laboratory effect is not necessarily a health hazard. Compare exposure profiles—not merely the number of devices—for 5G, emerging 6G, Wi-Fi, satellites, IoT, wearables, smart homes/cities, autonomous vehicles, wireless medical devices, and smart meters. Exposure characteristics differ. Require updated assessments when technologies change.\n\nQ14–15: Fund rigorous studies of pollinators, birds, plants, and livestock, controlling for pesticides, habitat, climate, and other factors. An evidence map found hundreds of studies with quality limitations. Evaluate installations near homes, schools, childcare and healthcare facilities using site-specific measurements, cumulative neighborhood assessments, antenna characteristics, and realistic small-cell operation.\n\nQ16–17: NIH should fund independent, preregistered long-term epidemiology, developmental research, animal replication, and mechanistic studies. FDA should evaluate consumer and medical devices; CDC should coordinate surveillance and risk communication. FCC and health agencies should publicly explain how new evidence informs exposure standards and disclose conflicts of interest.\n\nQ18: I request (1) a time-bound, public reassessment of RF limits and their treatment of long-term, multi-source exposure; (2) publicly accessible environmental monitoring; (3) special review and community consultation for installations near schools and homes; (4) funding for ecological and human studies independent of industry; (5) practical wired options and clear device settings for consumers; and (6) a transparent process to report concerns and challenge incomplete compliance assessments. The 2021 decision in Environmental Health Trust v. FCC required the FCC to better explain its treatment of certain health and environmental issues; it did not find that 5G causes disease. A rigorous, updated public accounting is necessary.\n\nSources: NTP, Cell Phone Radio Frequency Radiation Studies (2018); IARC Monographs Vol. 102 (2013); ICNIRP RF Guidelines (2020); Environmental Health Trust v. FCC, 9 F.4th 893 (D.C. Cir. 2021); WHO-commissioned systematic review of RF exposure and cancer (Environment International, 2024).","attachments":[],"attachment_inventory":true,"withheld":false,"source":"https://www.regulations.gov/comment/HHS-OASH-2026-0397-2898","tags":["cancer-tumors","child-development","health-experiences","sleep-cognition","exposure-places","policy-standards","research-evidence"],"source_hash":"c8b77751ddf9eb1e1040670dae31065586b824132bac06fb5f030d5591308180","slug":"cancer-tumors-comment-2898","classification":{"id":"HHS-OASH-2026-0397-2898","body_sha256":"95e8185f4c46599b4d1bc3f60f0b383c5c512895ceb3832b7a33c81b639fa5f9","status":"ai_reviewed","primary_topic":"standards","topics":[{"id":"standards","evidence":"Q18: I request (1) a time-bound, public reassessment of RF limits and their treatment of long-term, multi-source exposure; (2"},{"id":"research","evidence":".\n\nQ16–17: NIH should fund independent, preregistered long-term epidemiology, developmental research, animal repl"},{"id":"environment","evidence":"ange.\n\nQ14–15: Fund rigorous studies of pollinators, birds, plants, and livestock, controlling for pesticides, "},{"id":"children","evidence":"ng, real-world exposures, including for children and ecosystems.\n\nQ3–4: Sources of concern include cell towe"},{"id":"occupational","evidence":"hildren, pregnant people, older adults, workers near transmitters, people with implanted medical devices (including interfere"},{"id":"ehs","evidence":"ptoms reported by people identifying as electromagnetically hypersensitive without presuming an RF cause.\n\nQ12–13: Investigate reprodu"},{"id":"optical","evidence":" independent of industry; (5) practical wired options and clear device settings for consumers; and (6) a transpar"},{"id":"cancer","evidence":"ivacy-protective surveillance combining cancer registries, occupational and environmental monitoring, longitudinal co"}],"summary":"Requests a transparent reassessment of long-term, multi-source exposure limits, independent monitoring and research, ecological studies, privacy-protective reporting and wired alternatives, while emphasizing uncertainty and avoiding causal assumptions.","reviewed_at":"2026-10-15T03:51:16Z","review_method":"Source-based AI review of complete published comment bodies; exact topic evidence; attachments and external links not reviewed.","review_source_sha256":"6320d60a2aa22d221a22ab91d76eede2c576b7137d3dfa8cac5772bafc141fd6","source_url":"https://rfsafe.net/hhs-comments/data/catalog.json","scope":"Original comment body; attachments excluded"},"forum_topics":["standards","research","environment","children","occupational","ehs","optical","cancer"],"primary_topic":"standards","forum_title":"Requests a transparent reassessment of long-term, multi-source exposure limits, independent monitoring an…"}